Journal of the American Academy of Dermatology
Volume 59, Issue 5 , Pages 792-800, November 2008

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: Assessment of efficacy and safety in 2813 patients

  • Diane Thiboutot, MD

      Affiliations

    • Department of Dermatology, the Pennsylvania State University College of Medicine, Hershey, Pennsylvania
    • ,
  • Andrea Zaenglein, MD

      Affiliations

    • Department of Dermatology, the Pennsylvania State University College of Medicine, Hershey, Pennsylvania
    • ,
  • Jonathan Weiss, MD

      Affiliations

    • Department of Dermatology, Gwinnett Clinical Research Center, Snellville, Georgia
    • ,
  • Guy Webster, MD, PhD

      Affiliations

    • Jefferson Dermatology Service, Wilmington Department of Veterans Affairs Medical Center, Wilmington, Pennsylvania
    • ,
  • Barry Calvarese, MS

      Affiliations

    • Dow Pharmaceutical Sciences Inc, Petaluma, California
    • ,
  • Diana Chen, MD

      Affiliations

    • Arcutis Pharmaceuticals, Redwood City, California
    • Corresponding Author InformationReprint requests: Diana Chen, MD, Medical Affairs, Arcutis Pharmaceuticals, 900 Island Drive, Suite 210, Redwood City, CA 94065.

Accepted 24 June 2008. published online 22 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by Arcutis Pharmaceuticals.

 Disclosure: Dr Thiboutot has been an investigator, consultant, or advisory board member for Allergan Inc, Arcutis Inc, Dusa Inc, Galderma Inc, Stiefel Inc, QLT Inc, and Medicis Inc, and has received honoraria or grant support. Dr Zaenglein has served as an advisory board member for Sanofi Aventis Inc, a speaker for Galderma Inc, an investigator for Arcutis Inc, and has received honoraria or grant support. Dr Weiss has served as an investigator and consultant for Arcutis Inc and has received grant support. Dr Webster has served as an investigator and consultant for Arcutis Inc, a consultant for Allergan Inc, Stiefel Inc, Sanofi Aventis Inc, Dusa Inc, Medicis Inc, Ortho Inc, QLT Inc, Galderma Inc, Coria Inc, Cutanea Inc, and has received honoraria or grant support. Mr Calvarese is an employee of Dow Pharmaceutical Sciences, Inc. Dr Chen is an employee of Arcutis Pharmaceuticals.

PII: S0190-9622(08)00806-2

doi:10.1016/j.jaad.2008.06.040

Journal of the American Academy of Dermatology
Volume 59, Issue 5 , Pages 792-800, November 2008

Article Tools

* Image Usage & Resolution